Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory, Business Update

Seres Therapeutics to Host First Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on May 9, 2023


Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on May 9, 2023 at 8:30 a.m. ET to discuss first quarter results and provide a general business update, including initial SER-155 Phase 1b safety and pharmacology results from study Cohort 1.

To access the conference call, please dial 800-715-9871 (domestic) or 646-307-1963 (international) and reference the conference ID number 5098595. To join the live webcast, please visit the "Investors and News" section of the Seres website at www.serestherapeutics.com.

A webcast replay will be available on the Seres website beginning approximately two hours after the event and will be archived for approximately 21 days.

About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres' lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. Seres is evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in medically compromised patients. The Company is also conducting research to inform further development of microbiome therapeutics for ulcerative colitis.

For more information, please visit www.serestherapeutics.com.


These press releases may also interest you

at 12:05
Transaction in Own Shares
Transaction in Own Shares 4 July, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 4 July, 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to...

at 12:04
Canadian Investment Regulatory Organization Trade Resumption - VGCX
Trading resumes in: Company: Victoria Gold Corp. TSX Symbol: VGCX All Issues: Yes Resumption (ET): 12:15 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...

at 12:00
USO and John Deere Join Forces To Support Those Who Serve
John Deere has made a two-year, $100,000 commitment to USO, the leading nonprofit dedicated to strengthening the wellbeing of America's military members and their families. This donation will enable John Deere employees and customers to show their...

at 11:46
MAGNETIC NORTH ACQUISITION CORP. PROVIDES BI-WEEKLY UPDATE ?ON STATUS OF MANAGEMENT CEASE TRADE ORDER ?
Magnetic North Acquisition Corp.  ("Magnetic North" or the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on May 7, 2024 (the "MCTO") by its principal regulator, the Alberta Securities...

at 11:25
CSL Highlights Major ESG Achievements in 2023 Sustainability Report
The CSL Group ("CSL"), a global leader in sustainable marine transportation solutions, today unveiled its 2023 Corporate Sustainability Report, reflecting its commitment to transparency and accountability in environmental, social, and governance...

at 11:24
Canadian Investment Regulatory Organization Trade Resumption - GXU
Trading resumes in: Company: GoviEx Uranium Inc. TSX-Venture Symbol: GXU All Issues: Yes Resumption (ET): 11:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts...

More news about Business...


News published on and distributed by: